Maravai LifeSciences  Inc. logo

Maravai LifeSciences Inc.

MRVI | NASDAQ
Chart Builder DCF Calculator
$7.17
+$0.20 (+2.87%)
At close: Sep 21, 2026, 4:00 PM ET
$7.30
+$0.13 (+1.81%)
Pre-market: Sep 22, 2026, 4:25 AM ET

Market Data

Market Cap
$1.93B
Enterprise Value
$1.94B
Beta
0.61
Average Volume
3.31M
Shares Outstanding (Diluted)
147.22M
Shares Change YoY
2.07%
Institutional Ownership
82.93%
Exchange
NASDAQ
ISIN
US56600D1072

Price Performance

Price Change 1M
-15.7%
Price Change 3M
33.5%
Price Change 6M
130.6%
Price Change YTD
110.9%
Price Change 1Y
160.7%
Price Change 3Y
-25.3%
Price Change 5Y
-85.5%
1M CAGR (ann.)
11.5%
1Y CAGR (ann.)
148.0%
5Y CAGR (ann.)
-31.8%
All-Time CAGR
-22.1%

Valuation

PE Ratio
-13.28
Forward PE
N/A
PEG Ratio
-0.14
Forward PEG
0.80
PS Ratio
9.49
Forward PS
8.80
PB Ratio
9.68
P/FCF Ratio
-56.41
P/Adj. FCF Ratio
-32.41
P/OCF Ratio
-42.18
EV/Sales
9.30
EV/EBIT
-20.32
EV/EBITDA
-28.94
EV/FCF
-55.29
Earnings Yield
-7.5%
FCF Yield
-1.8%
Adj. FCF Yield
-3.1%

Financial Health

Net Cash
$39.38M
Total Debt
$30.72M
Cash & Short-Term Investments
$70.09M
Total Assets
$603.75M
Current Ratio
4.05
Quick Ratio
2.98
Debt / Equity Ratio
0.86
Debt / EBITDA
-0.46
Debt / FCF
-0.87
OCF / Debt
-0.82
Interest Coverage
4.01
Altman Z-Score
4.70
Piotroski F-Score
5

Margins & Profitability

Gross Profit Margin
34.6%
Operating Profit Margin
46.0%
EBITDA Margin
-27.4%
Net Profit Margin
-37.1%
FCF Margin
-16.8%
Adj. FCF Margin
-29.3%
SBC / Revenue
12.5%
SBC Impact (per share)
-74.1%

Returns

Return on Assets
-12.8%
Return on Equity
-35.4%
Return on Invested Capital
16.9%
Return on Capital Employed
17.0%
Return on Tangible Assets
-23.0%

Historical Growth (CAGR)

Revenue CAGR 3Y
-27.3%
Revenue CAGR 5Y
-17.7%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
23.8%
EPS CAGR 5Y
-291.1%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-28.2%
FCF CAGR 5Y
-103.1%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
14
EPS Growth Next 3Y
24.7%
Revenue Growth Next 3Y
6.6%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$7
Price Target Upside
-2.4%

Cash Flow

Operating Cash Flow
$-25.26M
Free Cash Flow
$-35.11M
Adj. Free Cash Flow
$-61.11M
FCF Per Share
-$0.24
OCF Per Share
-$0.17
OCF/S Ratio
-12.1%

Income Statement

Revenue
$208.78M
Gross Profit
$72.25M
Operating Income
$96.09M
EBITDA
$-67.07M
Net Income
$-77.39M
EPS (Diluted)
-$0.54
Revenue / Employee
$503.07K
Profit / Employee
$-186.47K
Employees
415

© 2026 bestshares.com. All rights reserved.